Journal of clinical gastroenterology

Effects of a Multispecies Probiotic on Ongoing IBS-like Symptoms in Celiac Patients

Updated

Abstract

In a study of 109 patients, probiotic treatment resulted in a 15.3% treatment success rate compared to 3.8% for placebo.

  • severity scores decreased significantly in patients receiving probiotics compared to those on placebo.
  • The Gastrointestinal Symptom Rating Scale scores also showed a notable reduction in the probiotic group.
  • Probiotic treatment was associated with an increase in specific gut bacteria, including Bifidobacterium.
  • No adverse events were reported during the study period.

Simplified

Key numbers

21.4%
Decrease in -SSS Score
Probiotics vs. placebo after treatment.
15.3% vs. 3.8%
Treatment Success Rate
Success rates in probiotic vs. placebo groups.
1.33×
Increase in Beneficial Bacteria
Increase in bifidobacteria after 6 weeks of probiotic treatment.

Full Text

We can’t show the full text here under this license.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free